Organon (OGN) Misses Q3 EPS by 3c, provides guidance

Organon (NYSE: OGN) reported Q3 EPS of $0.87, $0.03 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $1.58 billion versus the consensus estimate of $1.56 billion.

GUIDANCE:

Organon sees FY2024 revenue of $6.375-6.425 billion, versus the consensus of $6.394 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
• Wedbush Starts Eupraxia Pharmaceuticals (EPRX) at Outperform